Bluechiip (BCT.AX) Aandeel Koers
Bluechiip Koers
De omzet is de afgelopen 12 jaar met 30,4% per jaar gegroeid tot 484.700,00 AUD. De nettowinstmarge van Bluechiip ligt op -1.199,3% en is ten opzichte van -1.910,5% enkele jaren eerder gestegen.
Bluechiip aandeelkoers
Deze data ophalen via de Eulerpool API
100.000 requests/maand gratis · geen creditcard
Bluechiip bedrijfsmodel & aandelenanalyse
Veelgestelde vragen over Bluechiip
Bluechiip Ltd is an innovative technology company specializing in advanced tracking solutions. Founded in 2005, Bluechiip has revolutionized the way temperature-sensitive assets are monitored and tracked. The company's breakthrough technology combines both passive RFID and MEMS technologies to provide highly accurate and reliable identification of assets in extreme conditions. Bluechiip's patented product, the Bluechiip Smart, is leading the industry in healthcare, life sciences, and sample tracking. With a strong focus on innovation and continuous improvement, Bluechiip Ltd is committed to delivering cutting-edge tracking solutions to meet the evolving needs of its customers.
The business model of Bluechiip Ltd revolves around providing innovative tracking solutions for various industries. The company specializes in developing and commercializing advanced tracking technologies using its proprietary chip and software platform. Bluechiip's unique microchips enable real-time and robust tracking of valuable assets, such as biological samples, electronic components, and medical devices. By incorporating wireless communication and temperature sensing capabilities, Bluechiip's tracking solutions offer accurate monitoring and improved efficiency in inventory management. The company's technology finds applications in healthcare, pharmaceuticals, cryogenic storage, and logistics sectors, ensuring traceability and enhancing supply chain management. Bluechiip Ltd aims to deliver reliable and secure tracking solutions to facilitate seamless operations and safeguard valuable assets for its clients.
Bluechiip Ltd is primarily active in the healthcare and life sciences industries.
The main competitors of Bluechiip Ltd in the market include companies like Zymergen Inc., NanoString Technologies Inc., and Fluidigm Corporation.
Bluechiip Ltd has achieved several significant milestones. The company successfully developed its innovative wireless tracking solution, which combines a unique microchip with a passive RFID tag. Bluechiip's technology aims to revolutionize the storage and monitoring of critical biological samples, such as those used in healthcare and pharmaceutical industries. The company has also formed strategic partnerships with leading organizations in various sectors, including healthcare and biobanking, to showcase the potential of its solution. Bluechiip continues to enhance its product portfolio and expand its market reach, positioning itself as a key player in the field of advanced tracking and monitoring systems.
Bluechiip Ltd is primarily present in Australia.
Bluechiip Ltd represents values of innovation, reliability, and sustainability in its corporate philosophy. The company focuses on developing and commercializing advanced tracking solutions using its unique and patented technology. Bluechiip's solution provides a highly reliable, tamper-proof, and cost-effective method for tracking and monitoring critical samples, such as those used in healthcare, research, and logistics industries. With a commitment to continuous improvement and a customer-centric approach, Bluechiip aims to provide exceptional solutions that improve efficiency, reduce errors, and enhance overall operational effectiveness. As a result, Bluechiip Ltd sets itself apart as a leading provider of cutting-edge tracking technology solutions.
Het aandeel Bluechiip (BCT.AX) is genoteerd aan 2 beurzen, waaronder: ASX (BCT.AX), Frankfurt (1BL.F).
Bluechiip Ltd is a leading provider of innovative solutions in the cryo-biology industry. The company specializes in developing sample management systems based on the unique Bluechiip technology to improve efficiency and accuracy in cryo-biology. The Bluechiip technology combines RFID and MEMS technology to identify samples even under extreme conditions of -196 degrees Celsius. It offers various products and solutions tailored to the needs of customers, including a sample management system with automatic sample tracking and real-time data monitoring. Bluechiip also partners with other companies in the cryo-biology industry to expand its product portfolio and develop new applications. The company invests in research and development to improve its product portfolio and develop new technologies. It focuses on markets such as biobanks, research institutions, cell therapy, clinical trials, and bioproduction and supply chain management. The Bluechiip technology provides enhanced data capture, increased security, and more efficient sample management solutions for the cryo-biology industry.
De verwachte omzet van Bluechiip bedraagt 8,29 Miljoen AUD. Deze cijfers zijn gebaseerd op huidige financiële gegevens en weerspiegelen de bedrijfsresultaten van het bedrijf.
De winst kan momenteel niet worden berekend voor Bluechiip.
De P/E-ratio kan momenteel niet worden berekend voor Bluechiip.
De P/S-ratio kan momenteel niet worden berekend voor Bluechiip.
De Eulerpool Kwaliteitsscore voor Bluechiip is 4/10.
De ISIN van Bluechiip is AU000000BCT7. De ISIN (International Securities Identification Number) is een wereldwijd unieke identificatie voor wertpapieren.
De WKN van Bluechiip is A1JFYH. De WKN (Wertpapierkennnummer) is een zescijferig Duits identificatienummer voor wertpapieren.
Het tickersymbool van Bluechiip is BCT.AX. Onder dit beurstickersymbool wordt het Bluechiip-aandeel op de beurs verhandeld.
Bluechiip aandeel
Alle fundamentals en diepgaande analyse van Bluechiip
Onze aandelenanalyse van het Bluechiip-aandeel omvat belangrijke financiële kerncijfers zoals de omzet, de winst, de P/E-ratio, de P/S-ratio, de EBIT, evenals informatie over het dividend. Daarnaast bekijken we aspecten zoals aandelen, marktkapitalisatie, schulden, eigen vermogen en verplichtingen van Bluechiip. Als u meer gedetailleerde informatie zoekt over deze onderwerpen, bieden we op onze subpagina's uitgebreide analyses: